FHIR IG analytics
| Package | us.nlm.vsac |
| Resource Type | ValueSet |
| Id | ValueSet-2.16.840.1.113762.1.4.1235.231.json |
| FHIR Version | R4 |
| Source | https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1235.231/expansion |
| URL | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.231 |
| Version | 20230118 |
| Status | active |
| Date | 2023-01-18T01:03:05-05:00 |
| Name | InfluenzaVaccineCN_HD_CPT |
| Title | Influenza Vaccine CN_HD_CPT |
| Realm | us |
| Authority | hl7 |
| Description | b.well created value set by Sr. Clinical Business Analyst for Influenza Vaccine - Adult Care Need. |
| Purpose | (Clinical Focus: The intent of this value set is for the purpose of defining the clinical codes that constitute Influenza Vaccine - Adult Care Need for inclusion and utilization in patients/users connected heath.),(Data Element Scope: Influenza Vaccine - Adult Care Need for b.well.),(Inclusion Criteria: Codes that constitute the Flu Vaccine - Adult & Influenza Vaccine - Adult Care Need for b.well.),(Exclusion Criteria: N/A) |
Resources that use this resource
Resources that this resource uses
| CodeSystem |
| cpt | Current Procedural Terminology (CPT®) |
Narrative
No narrative content found in resource
Source1
{
"resourceType": "ValueSet",
"id": "2.16.840.1.113762.1.4.1235.231",
"meta": {
"versionId": "6",
"lastUpdated": "2023-12-21T17:43:03.000-05:00",
"profile": [
"http://hl7.org/fhir/StructureDefinition/shareablevalueset",
"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
]
},
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-author",
"valueContactDetail": {
"name": "B.well Connected Health Author"
}
},
{
"url": "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
"valueDate": "2024-06-04"
},
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
"valueDate": "2023-01-18"
}
],
"url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.231",
"identifier": [
{
"system": "urn:ietf:rfc:3986",
"value": "urn:oid:2.16.840.1.113762.1.4.1235.231"
}
],
"version": "20230118",
"name": "InfluenzaVaccineCN_HD_CPT",
"title": "Influenza Vaccine CN_HD_CPT",
"status": "active",
"date": "2023-01-18T01:03:05-05:00",
"publisher": "B.well Connected Health Steward",
"description": "b.well created value set by Sr. Clinical Business Analyst for Influenza Vaccine - Adult Care Need.",
"jurisdiction": [
{
"coding": [
{
"system": "urn:iso:std:iso:3166",
"code": "US"
}
]
}
],
"purpose": "(Clinical Focus: The intent of this value set is for the purpose of defining the clinical codes that constitute Influenza Vaccine - Adult Care Need for inclusion and utilization in patients/users connected heath.),(Data Element Scope: Influenza Vaccine - Adult Care Need for b.well.),(Inclusion Criteria: Codes that constitute the Flu Vaccine - Adult & Influenza Vaccine - Adult Care Need for b.well.),(Exclusion Criteria: N/A)",
"compose": {
"include": [
{
"system": "http://www.ama-assn.org/go/cpt",
"concept": [
{
"code": "90630",
"display": "Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, for intradermal use"
},
{
"code": "90644",
"display": "Meningococcal conjugate vaccine, serogroups C & Y and Haemophilus influenzae type b vaccine (Hib-MenCY), 4 dose schedule, when administered to children 6 weeks-18 months of age, for intramuscular use"
},
{
"code": "90645",
"display": "Hemophilus influenza b vaccine (Hib), HbOC conjugate (4 dose schedule), for intramuscular use"
},
{
"code": "90646",
"display": "Hemophilus influenza b vaccine (Hib), PRP-D conjugate, for booster use only, intramuscular use"
},
{
"code": "90647",
"display": "Haemophilus influenzae type b vaccine (Hib), PRP-OMP conjugate, 3 dose schedule, for intramuscular use"
},
{
"code": "90648",
"display": "Haemophilus influenzae type b vaccine (Hib), PRP-T conjugate, 4 dose schedule, for intramuscular use"
},
{
"code": "90653",
"display": "Influenza vaccine, inactivated (IIV), subunit, adjuvanted, for intramuscular use"
},
{
"code": "90654",
"display": "Influenza virus vaccine, trivalent (IIV3), split virus, preservative-free, for intradermal use"
},
{
"code": "90655",
"display": "Influenza virus vaccine, trivalent (IIV3), split virus, preservative free, 0.25 mL dosage, for intramuscular use"
},
{
"code": "90656",
"display": "Influenza virus vaccine, trivalent (IIV3), split virus, preservative free, 0.5 mL dosage, for intramuscular use"
},
{
"code": "90657",
"display": "Influenza virus vaccine, trivalent (IIV3), split virus, 0.25 mL dosage, for intramuscular use"
},
{
"code": "90658",
"display": "Influenza virus vaccine, trivalent (IIV3), split virus, 0.5 mL dosage, for intramuscular use"
},
{
"code": "90660",
"display": "Influenza virus vaccine, trivalent, live (LAIV3), for intranasal use"
},
{
"code": "90661",
"display": "Influenza virus vaccine, trivalent (ccIIV3), derived from cell cultures, subunit, preservative and antibiotic free, 0.5 mL dosage, for intramuscular use"
},
{
"code": "90662",
"display": "Influenza virus vaccine (IIV), split virus, preservative free, enhanced immunogenicity via increased antigen content, for intramuscular use"
},
{
"code": "90672",
"display": "Influenza virus vaccine, quadrivalent, live (LAIV4), for intranasal use"
},
{
"code": "90673",
"display": "Influenza virus vaccine, trivalent (RIV3), derived from recombinant DNA, hemagglutinin (HA) protein only, preservative and antibiotic free, for intramuscular use"
},
{
"code": "90674",
"display": "Influenza virus vaccine, quadrivalent (ccIIV4), derived from cell cultures, subunit, preservative and antibiotic free, 0.5 mL dosage, for intramuscular use"
},
{
"code": "90682",
"display": "Influenza virus vaccine, quadrivalent (RIV4), derived from recombinant DNA, hemagglutinin (HA) protein only, preservative and antibiotic free, for intramuscular use"
},
{
"code": "90685",
"display": "Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.25 mL dosage, for intramuscular use"
},
{
"code": "90686",
"display": "Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use"
},
{
"code": "90687",
"display": "Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.25 mL dosage, for intramuscular use"
},
{
"code": "90688",
"display": "Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.5 mL dosage, for intramuscular use"
},
{
"code": "90689",
"display": "Influenza virus vaccine, quadrivalent (IIV4), inactivated, adjuvanted, preservative free, 0.25 mL dosage, for intramuscular use"
},
{
"code": "90694",
"display": "Influenza virus vaccine, quadrivalent (aIIV4), inactivated, adjuvanted, preservative free, 0.5 mL dosage, for intramuscular use"
},
{
"code": "90697",
"display": "Diphtheria, tetanus toxoids, acellular pertussis vaccine, inactivated poliovirus vaccine, Haemophilus influenzae type b PRP-OMP conjugate vaccine, and hepatitis B vaccine (DTaP-IPV-Hib-HepB), for intramuscular use"
},
{
"code": "90698",
"display": "Diphtheria, tetanus toxoids, acellular pertussis vaccine, Haemophilus influenzae type b, and inactivated poliovirus vaccine, (DTaP-IPV/Hib), for intramuscular use"
},
{
"code": "90721",
"display": "Diphtheria, tetanus toxoids, and acellular pertussis vaccine and Hemophilus influenza B vaccine (DTaP/Hib), for intramuscular use"
},
{
"code": "90748",
"display": "Hepatitis B and Haemophilus influenzae type b vaccine (Hib-HepB), for intramuscular use"
},
{
"code": "90756",
"display": "Influenza virus vaccine, quadrivalent (ccIIV4), derived from cell cultures, subunit, antibiotic free, 0.5 mL dosage, for intramuscular use"
}
]
}
]
},
"expansion": {
"identifier": "urn:uuid:3053b16c-e146-4b4f-80cc-76a214e8d55d",
"timestamp": "2025-05-23T20:20:35-04:00",
"total": 25,
"contains": [
{
"system": "http://www.ama-assn.org/go/cpt",
"version": "2025",
"code": "90644",
"display": "Meningococcal conjugate vaccine, serogroups C & Y and Haemophilus influenzae type b vaccine (Hib-MenCY), 4 dose schedule, when administered to children 6 weeks-18 months of age, for intramuscular use"
},
{
"system": "http://www.ama-assn.org/go/cpt",
"version": "2025",
"code": "90647",
"display": "Haemophilus influenzae type b vaccine (Hib), PRP-OMP conjugate, 3 dose schedule, for intramuscular use"
},
{
"system": "http://www.ama-assn.org/go/cpt",
"version": "2025",
"code": "90648",
"display": "Haemophilus influenzae type b vaccine (Hib), PRP-T conjugate, 4 dose schedule, for intramuscular use"
},
{
"system": "http://www.ama-assn.org/go/cpt",
"version": "2025",
"code": "90653",
"display": "Influenza vaccine, inactivated (IIV), subunit, adjuvanted, for intramuscular use"
},
{
"system": "http://www.ama-assn.org/go/cpt",
"version": "2025",
"code": "90655",
"display": "Influenza virus vaccine, trivalent (IIV3), split virus, preservative free, 0.25 mL dosage, for intramuscular use"
},
{
"system": "http://www.ama-assn.org/go/cpt",
"version": "2025",
"code": "90656",
"display": "Influenza virus vaccine, trivalent (IIV3), split virus, preservative free, 0.5 mL dosage, for intramuscular use"
},
{
"system": "http://www.ama-assn.org/go/cpt",
"version": "2025",
"code": "90657",
"display": "Influenza virus vaccine, trivalent (IIV3), split virus, 0.25 mL dosage, for intramuscular use"
},
{
"system": "http://www.ama-assn.org/go/cpt",
"version": "2025",
"code": "90658",
"display": "Influenza virus vaccine, trivalent (IIV3), split virus, 0.5 mL dosage, for intramuscular use"
},
{
"system": "http://www.ama-assn.org/go/cpt",
"version": "2025",
"code": "90660",
"display": "Influenza virus vaccine, trivalent, live (LAIV3), for intranasal use"
},
{
"system": "http://www.ama-assn.org/go/cpt",
"version": "2025",
"code": "90661",
"display": "Influenza virus vaccine, trivalent (ccIIV3), derived from cell cultures, subunit, antibiotic free, 0.5 mL dosage, for intramuscular use"
},
{
"system": "http://www.ama-assn.org/go/cpt",
"version": "2025",
"code": "90662",
"display": "Influenza virus vaccine (IIV), split virus, preservative free, enhanced immunogenicity via increased antigen content, for intramuscular use"
},
{
"system": "http://www.ama-assn.org/go/cpt",
"version": "2025",
"code": "90672",
"display": "Influenza virus vaccine, quadrivalent, live (LAIV4), for intranasal use"
},
{
"system": "http://www.ama-assn.org/go/cpt",
"version": "2025",
"code": "90673",
"display": "Influenza virus vaccine, trivalent (RIV3), derived from recombinant DNA, hemagglutinin (HA) protein only, preservative and antibiotic free, for intramuscular use"
},
{
"system": "http://www.ama-assn.org/go/cpt",
"version": "2025",
"code": "90674",
"display": "Influenza virus vaccine, quadrivalent (ccIIV4), derived from cell cultures, subunit, preservative and antibiotic free, 0.5 mL dosage, for intramuscular use"
},
{
"system": "http://www.ama-assn.org/go/cpt",
"version": "2025",
"code": "90682",
"display": "Influenza virus vaccine, quadrivalent (RIV4), derived from recombinant DNA, hemagglutinin (HA) protein only, preservative and antibiotic free, for intramuscular use"
},
{
"system": "http://www.ama-assn.org/go/cpt",
"version": "2025",
"code": "90685",
"display": "Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.25 mL dosage, for intramuscular use"
},
{
"system": "http://www.ama-assn.org/go/cpt",
"version": "2025",
"code": "90686",
"display": "Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use"
},
{
"system": "http://www.ama-assn.org/go/cpt",
"version": "2025",
"code": "90687",
"display": "Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.25 mL dosage, for intramuscular use"
},
{
"system": "http://www.ama-assn.org/go/cpt",
"version": "2025",
"code": "90688",
"display": "Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.5 mL dosage, for intramuscular use"
},
{
"system": "http://www.ama-assn.org/go/cpt",
"version": "2025",
"code": "90689",
"display": "Influenza virus vaccine, quadrivalent (IIV4), inactivated, adjuvanted, preservative free, 0.25 mL dosage, for intramuscular use"
},
{
"system": "http://www.ama-assn.org/go/cpt",
"version": "2025",
"code": "90694",
"display": "Influenza virus vaccine, quadrivalent (aIIV4), inactivated, adjuvanted, preservative free, 0.5 mL dosage, for intramuscular use"
},
{
"system": "http://www.ama-assn.org/go/cpt",
"version": "2025",
"code": "90697",
"display": "Diphtheria, tetanus toxoids, acellular pertussis vaccine, inactivated poliovirus vaccine, Haemophilus influenzae type b PRP-OMP conjugate vaccine, and hepatitis B vaccine (DTaP-IPV-Hib-HepB), for intramuscular use"
},
{
"system": "http://www.ama-assn.org/go/cpt",
"version": "2025",
"code": "90698",
"display": "Diphtheria, tetanus toxoids, acellular pertussis vaccine, Haemophilus influenzae type b, and inactivated poliovirus vaccine, (DTaP-IPV/Hib), for intramuscular use"
},
{
"system": "http://www.ama-assn.org/go/cpt",
"version": "2025",
"code": "90748",
"display": "Hepatitis B and Haemophilus influenzae type b vaccine (Hib-HepB), for intramuscular use"
},
{
"system": "http://www.ama-assn.org/go/cpt",
"version": "2025",
"code": "90756",
"display": "Influenza virus vaccine, quadrivalent (ccIIV4), derived from cell cultures, subunit, antibiotic free, 0.5 mL dosage, for intramuscular use"
}
]
}
}
FHIR
FHIRsmith